What are the treatment options for managing abdominal pain in Irritable Bowel Syndrome (IBS) with diarrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Treatment Options for Abdominal Pain in IBS with Diarrhea

The most effective treatment for managing abdominal pain in Irritable Bowel Syndrome (IBS) with diarrhea involves a combination of dietary changes, soluble fiber supplements, and medications such as loperamide and antispasmodics 1.

  • Dietary Changes: Patients should be advised to take regular exercise and offered first-line dietary advice, which may include increasing soluble fiber intake, such as ispaghula, starting with a low dose of 3-4 g/day and gradually increasing as needed and tolerated 1.
  • Soluble Fiber Supplements: Soluble fiber, such as ispaghula, is an effective treatment for global symptoms and abdominal pain in IBS, but insoluble fiber should be avoided as it may exacerbate symptoms 1.
  • Loperamide: Loperamide may be an effective treatment for diarrhea in IBS, starting with a dose of 2-4 mg orally after each loose stool, up to a maximum of 16 mg per day, but careful titration of the dose is necessary to avoid side effects such as abdominal pain, bloating, nausea, and constipation 1.
  • Antispasmodics: Certain antispasmodics may be an effective treatment for global symptoms and abdominal pain in IBS, but they can cause side effects such as dry mouth, visual disturbance, and dizziness 1.
  • Peppermint Oil: Peppermint oil may be an effective treatment for global symptoms and abdominal pain in IBS, but it can cause gastro-oesophageal reflux as a side effect 1.

It's essential to start with low doses and gradually increase as needed and tolerated, under the guidance of a healthcare provider. Additionally, patients should be counselled about the potential benefits and risks of each treatment option and monitored regularly to adjust the treatment plan as necessary.

From the FDA Drug Label

Hyoscyamine sulfate is effective as adjunctive therapy in the treatment of peptic ulcer. It can also be used to control gastric secretion, visceral spasm and hypermotility in spastic colitis, spastic bladder, cystitis, pylorospasm, and associated abdominal cramps May be used in functional intestinal disorders to reduce symptoms such as those seen in mild dysenteries, diverticulitis, and acute enterocolitis. For use as adjunctive therapy in the treatment of irritable bowel syndrome (irritable colon, spastic colon,mucous colitis) and functional gastrointestinal disorders Loperamide hydrochloride at the prescribed dosage

Treatment options for managing abdominal pain in Irritable Bowel Syndrome (IBS) with diarrhea include:

  • Loperamide to manage diarrhea symptoms
  • Hyoscyamine as adjunctive therapy to control visceral spasm and hypermotility in IBS 2 It is essential to use these medications at the prescribed dosage and under the guidance of a healthcare provider to minimize potential risks and interactions 3 2

From the Research

Treatment Options for Managing Abdominal Pain in IBS with Diarrhea

  • Nonpharmacological interventions include dietary and lifestyle modification, which are generally used as first-line therapy 4
  • Pharmacological interventions for the management of IBS-D include:
    • US Food and Drug Administration-approved agents: eluxadoline, rifaximin, and alosetron 4, 5, 6
    • Loperamide, which is useful for diarrhea but not for pain in IBS 7, 8, 6
    • Smooth muscle antispasmodics, which may help with abdominal pain 7, 8
    • Bile acid sequestrants, which may be useful in a small group of IBS patients with diarrhea 7
    • Antidepressants, such as tricyclic antidepressants and selective serotonin reuptake inhibitors, which may be useful for abdominal pain 7, 4, 8
    • Probiotics, which have demonstrated efficacy and safety in patients with IBS, but studies are inconsistent in strains examined, dosing, and treatment duration 4

Medications for Abdominal Pain in IBS-D

  • Eluxadoline has been shown to improve abdominal pain and stool consistency in patients with IBS-D 4, 5, 6
  • Rifaximin has been shown to improve abdominal pain and stool consistency in patients with IBS-D, and has a favorable safety profile 4, 6
  • Alosetron improves IBS symptoms, but is approved only for women with severe IBS-D 7, 4, 6
  • Tricyclic antidepressants and selective serotonin reuptake inhibitors may be useful for abdominal pain, but have limitations and side effects 7, 4, 8

Emerging Therapies

  • New drugs in development include the cholecystokinin antagonists and novel visceral analgesics 7
  • Emerging therapies with potential benefit in IBS-D include rifaximin and eluxadoline 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pharmacologic therapy for the irritable bowel syndrome.

The American journal of gastroenterology, 2003

Research

Treatment of irritable bowel syndrome.

Journal of clinical pharmacy and therapeutics, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.